How Will Healthcare M&A Change Under the Trump Administration?

The healthcare M&A market continues to be among the most active sectors. In 2016, there were 939 healthcare industry deals in the U.S. with an aggregate value of approximately $71.7 billion.

How will policies and goals of the new administration likely impact healthcare M&A trends? How will changes in the regulatory landscape affect M&A across all healthcare stakeholder segments? What can you expect to see in terms of antitrust regulation and enforcement? Manatt addresses these and other key questions in a new webinar for Bloomberg BNA.

Display-stock-market-numbers-and-graph

The session will:

  • Share an up-to-the-minute look at the status of ACA repeal and replace/repair efforts in Congress and the Executive Branch—and the implications of various scenarios on the healthcare sector.
  • Analyze the conflicting policy goals and political dynamics driving the debate around the ACA.
  • Review the changing landscape, critical issues and key takeaways for payer transactions in the wake of the failed insurance mega-mergers.
  • Examine hospital M&A and antitrust trends, including how the current climate might affect hospital transactions.
  • Explore the issues around forming and operating Accountable Care Organizations (ACOs).
  • Reveal the latest trends in state-action antitrust immunity for healthcare transactions.
  • Anticipate how healthcare antitrust enforcement may change with a new administration.
  • Present an update on regulatory and private antitrust activity in pharmaceutical pricing and pay-for-delay settlements.